{
    "clinical_study": {
        "@rank": "158064", 
        "arm_group": [
            {
                "arm_group_label": "IV ibuprofen", 
                "arm_group_type": "Experimental", 
                "description": "800mg ibuprofen"
            }, 
            {
                "arm_group_label": "ketorolac", 
                "arm_group_type": "Active Comparator", 
                "description": "30mg ketorolac"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to\n      ketorolac for the treatment of postoperative pain as measured by patient pain intensity\n      (Visual Analog Scale, VAS)"
        }, 
        "brief_title": "Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for knee arthroscopy\n\n        Exclusion Criteria:\n\n          -  Inadequate IV access.\n\n          -  History of allergy or hypersensitivity to any component of ibuprofen, ketorolac,\n             aspirin (or aspirin related products), NSAIDs, opioids or COX-2 inhibitors.\n\n          -  Less than 18 years of age.\n\n          -  Use of analgesics less than 8 hours prior to surgery.\n\n          -  Patients with active, clinically significant anemia.\n\n          -  History or evidence of asthma or heart failure.\n\n          -  Pregnant.\n\n          -  Recent history of chronic opioid use.\n\n          -  Concomitant use of probenecid.\n\n          -  Inability to understand the requirements of the study, be willing to provide written\n             informed consent (as evidenced by signature on an informed consent document approved\n             by an Institutional Review Board [IRB]), and agree to abide by the study restrictions\n             and to return for the required assessments.\n\n          -  Refusal to provide written authorization for use and disclosure of protected health\n             information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01901393", 
            "org_study_id": "CPI-CL-020"
        }, 
        "intervention": [
            {
                "arm_group_label": "IV ibuprofen", 
                "intervention_name": "IV ibuprofen", 
                "intervention_type": "Drug", 
                "other_name": "Caldolor"
            }, 
            {
                "arm_group_label": "ketorolac", 
                "intervention_name": "Ketorolac", 
                "intervention_type": "Drug", 
                "other_name": "Ketorolac Tromethamine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ibuprofen", 
                "Ketorolac Tromethamine", 
                "Ketorolac"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Post Operative Pain,", 
            "Pail relief"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Natalie@shrockresearch.com", 
                    "last_name": "Natalie Shrock, ARNP", 
                    "phone": "954-626-3743"
                }, 
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "Shrock Orthopedic Research"
                }, 
                "investigator": {
                    "last_name": "Kevin B Shrock, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Mahendrakumar_Shah@rush.edu", 
                    "last_name": "Mahendrakumar Shah, MD", 
                    "phone": "312-942-1982"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Bernard R Bach, Jr., MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Tracy Inman, LPN", 
                    "phone": "662-840-5856"
                }, 
                "facility": {
                    "address": {
                        "city": "Tupelo", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "38801"
                    }, 
                    "name": "North Mississippi Sports Medicine & Orthopaedic Clinic"
                }, 
                "investigator": {
                    "last_name": "Stephen Southworth, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Fernando.Arbona@osumc.edu", 
                    "last_name": "Andrew Otey", 
                    "phone": "614-366-1943"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "The Ohio State University Vexner Medical Center"
                }, 
                "investigator": {
                    "last_name": "Fernando Arbona, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Prospective, Randomized, Double-blind Study to Determine the Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery", 
        "overall_contact": {
            "email": "arock@cumberlandpharma.com", 
            "last_name": "Amy Rock, PhD", 
            "phone": "6152550068"
        }, 
        "overall_contact_backup": {
            "email": "bkaelin@cumberlandpharma.com", 
            "last_name": "Byron Kaelin, RN", 
            "phone": "6152550068"
        }, 
        "overall_official": {
            "affiliation": "Cumberland Pharmaceuticals Inc.", 
            "last_name": "Arthur P Wheeler, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain assessed using VAS (Visual Analog Scale)", 
            "measure": "Efficacy of Pain Relief", 
            "safety_issue": "No", 
            "time_frame": "First possible time post-surgery, an expected average of 6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01901393"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Amount of rescue med (in mg) will be measured", 
                "measure": "Rescue medication use in post-operative period", 
                "safety_issue": "No", 
                "time_frame": "Post-operative period until discharge, an expected average of 6 hours"
            }, 
            {
                "measure": "Time to first use of rescue med will be measured", 
                "safety_issue": "No", 
                "time_frame": "Post-operative period until discharge, an expected average of 6 hours"
            }, 
            {
                "description": "Measured using 2 question, 4 point scale.", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Post-operative period until discharge, an expected average of 6 hours"
            }, 
            {
                "measure": "Incidence of serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Post-operative period until discharge, an expected average of 6 hours"
            }
        ], 
        "source": "Cumberland Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cumberland Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}